No abstract available
MeSH terms
-
Clinical Trials as Topic
-
Drug Combinations
-
Ethanolamines / therapeutic use
-
Extracorporeal Circulation / instrumentation
-
Gene Silencing
-
Humans
-
Isoquinolines / therapeutic use
-
Mometasone Furoate, Formoterol Fumarate Drug Combination
-
Phosphodiesterase Inhibitors / therapeutic use
-
Pregnadienediols / therapeutic use
-
Pulmonary Disease, Chronic Obstructive / drug therapy*
-
Pyrimidinones / therapeutic use
-
RNA, Small Interfering / therapeutic use
-
Receptors, CCR2 / antagonists & inhibitors
-
Tobacco Use Cessation Devices
Substances
-
Drug Combinations
-
Ethanolamines
-
Isoquinolines
-
Mometasone Furoate, Formoterol Fumarate Drug Combination
-
Phosphodiesterase Inhibitors
-
Pregnadienediols
-
Pyrimidinones
-
RNA, Small Interfering
-
Receptors, CCR2
-
ensifentrine
Associated data
-
ClinicalTrials.gov/NCT00683722